Hasandalan, Irish .

HRN: 24-38-64  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/13/2024
CEFUROXIME 1.5GM (VIAL)
01/13/2024
01/19/2024
IV
1.5g
On Call Or Then Q8
LTCs
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: